Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction

Objective: In patients with heart failure (HF), anxiety and depression are commonly observed and confer an adverse outcome. The first-in-class member of angiotensin receptor-neprilysin inhibitor (ARNI), sacubitril/valsartan has been demonstrated to improve functional class and decrease mortality in...

Full description

Bibliographic Details
Main Authors: Jahanzeb Malik, Abdul Wahab Shahid, Mohsin Shah, Ghazanfar Rana, Ahmed Kamal, Hesham Naeem
Format: Article
Language:English
Published: Taylor & Francis Group 2021-09-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
angiotensin receptor-neprilysin inhibitor
heart failure
sacubitril/valsartan
hdrs
hads
Online Access:http://dx.doi.org/10.1080/20009666.2021.1942623

Similar Items

Similar Items